CFDE Data Portal | Search SLC25A20

	Label	Description
	SLC25A20 associations Collection (Entity type)	Associations for SLC25A20_associations
	SLC25A20 Down Gene Set (Entity type)	A Gene Set from LINCS
	SLC25A20 Up Gene Set (Entity type)	A Gene Set from LINCS
	SLC25A20 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SLC25A20 Gene (Entity type)	ENSG00000178537 - solute carrier family 25 member 20
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE207871 NPC knockdown S18 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 3 V 2 PAZOPANIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680,GSE182683 7 V 3 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE228430 FABP5 inhibition Huh-7 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

SLC25A20 associations

Associations for SLC25A20_associations

SLC25A20 Down

A Gene Set from LINCS

SLC25A20 Up

A Gene Set from LINCS

SLC25A20 associations.tsv

A file from IDG as part of the Harmonizome project

SLC25A20

ENSG00000178537 - solute carrier family 25 member 20

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

GSE207871 NPC knockdown S18 1 v 0 human up

A Gene Set from LINCS

GSE102467 3 V 2 PAZOPANIB HUMAN UP

A Gene Set from LINCS

GSE182680,GSE182683 7 V 3 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE228430 FABP5 inhibition Huh-7 2 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.